Law360 ( March 17, 2009, 12:00 AM EDT) -- The Supreme Court's 2005 decision in Dura Pharmaceuticals Inc. v. Broudo, 544 U.S. 336, made clear that a plaintiff alleging a securities fraud claim under Section 10(b), must prove that the defendant's misrepresentations proximately caused the losses suffered by plaintiff, and that merely proving inflation of a stock's price on the date of purchase is not sufficient to establish such loss causation. Id. at 345-46....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.